Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells. - Wikidata - wikimedia - TriplyDB

Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.

Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.

http://www.wikidata.org/entity/Q33527780

about

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction Comparative analysis of NRF2-responsive gene expression in AcPC-1 pancreatic cancer cell line Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines.Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity.Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases.Nrf2: control of sensitivity to carcinogens.NRF2 and p53: Januses in cancer?Membrane drug transporters and chemoresistance in human pancreatic carcinoma.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.Targeting reactive oxygen species in development and progression of pancreatic cancer.Modulation of nuclear factor E2-related factor-2 (Nrf2) activation by the stress response gene immediate early response-3 (IER3) in colonic epithelial cells: a novel mechanism of cellular adaption to inflammatory stress Raf/ERK/Nrf2 signaling pathway and MMP-7 expression involvement in the trigonelline-mediated inhibition of hepatocarcinoma cell migration.Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway.Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection.Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity.The KEAP1-NRF2 System in Cancer.The 'N-factors' in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer.Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.Superoxide Dismutases in Pancreatic Cancer.Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells.Correlation of NQO1 and Nrf2 in Female Genital Tract Cancer and Their Precancerous Lesions (Cervix, Endometrium and Ovary).Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.Effects of trigonelline inhibition of the Nrf2 transcription factor in vitro on Echinococcus granulosus.Colonic Lamina Propria Inflammatory Cells from Patients with IBD Induce the Nuclear Factor-E2 Related Factor-2 Thereby Leading to Greater Proteasome Activity and Apoptosis Protection in Human Colonocytes.Activation of Nrf2 signaling by natural products-can it alleviate diabetes?Clinicopathological characteristics of anaplastic carcinoma of the pancreas with rhabdoid features.Understanding life and death decisions in human leukaemias.2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense.

P2860

Q26865927-DBB64A85-3710-48BD-AAFE-ACE87F1664F8 Q28383407-B55147F0-9C38-4DC7-A45A-5CCE9E4685A4 Q28384407-89022A1C-5123-41CD-AD18-08E2323DC884 Q28396251-CE9C1360-7D51-465A-BABC-70B1BF7DEE72 Q28487677-391BBD63-EC7B-4449-AFA3-C636F8E15C49 Q34534013-72C7F0E2-8B55-405B-9AE7-FC3352109014 Q34993085-0755F5FD-136E-4291-ACDE-76226C915510 Q35048722-2028B697-C666-4788-B046-EE07CA2C823A Q35048909-D2EDE12E-1C9B-44DF-B55B-29B375AF6AEA Q35726483-B74EE467-1357-4487-BD31-DC47E7D78696 Q36844297-01E90A23-7246-48EA-B223-04460E98BC91 Q37285224-0A745D32-4FB0-41EE-A883-3E24E32F16B3 Q37620581-670D8E56-B2AF-472A-88E4-5885D7246629 Q37785105-B8CD5236-4E9B-46AC-9E2C-0164D9AC00B4 Q37849195-629FDEED-E0D6-4F14-A421-0923DC0842AD Q38061832-14E3A18D-8BFB-4E75-AAAF-22EA655FEBC3 Q38161328-7CC2C8A4-23D0-470A-83A3-E821885549D4 Q38869922-5179A011-E3A5-426C-9B41-D5ABC62DF45C Q39007517-5FE2F070-CA52-4D14-87D0-27C4E9EB9264 Q39047635-DE56CE5F-D792-4E9D-9592-64A6B4D8BC72 Q39135443-47159133-B7EB-421B-B398-13185A5A6EE4 Q39170232-3B58A02E-5BA4-485A-A14D-41FB346F9709 Q39242497-D0BFEE45-5E4D-4F29-B70D-1FE2608E92F6 Q39251887-122BFE26-225C-4032-B1BC-FAD57A888828 Q39317112-08F73C04-C4E2-4643-A6EA-BB029847DD86 Q39670791-A356D870-D26E-4082-994E-BD775012EFF0 Q41628271-A3DBD11F-DA95-435A-920C-3127A0ADB5DA Q41662731-27465821-7261-41F4-8B51-CDAECAEBBD96 Q41662828-7C46A139-C836-4423-9607-4AE33A7F0ADA Q42009367-5502100D-F26A-4BAC-9D79-5122CFB94571 Q45349809-6976403A-D741-4CA8-958C-96ECE1E28F08 Q46320699-A3F9D7CB-C820-44F4-8709-506C61A5BCEE Q46476904-5B6F015E-3CA5-4B8A-9A35-CAFC080B400A Q49385295-C2AF8A61-40E0-46C6-BDFB-BEC02657F446 Q53034326-530F4601-BA49-4C9B-AB5A-37D2277138F7 Q55071953-F75E9D38-668D-4A71-8C09-9EDFF8C935D2 Q55461978-61D1F638-F7EB-4D5B-A075-C5E84F4D34E4

P2860

Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.

http://www.wikidata.org/entity/Q33527780

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Nuclear factor (erythroid-deri ...... ce in pancreatic cancer cells.

@ast

Nuclear factor (erythroid-deri ...... ce in pancreatic cancer cells.

@en

Nuclear factor

@nl

type

label

Nuclear factor (erythroid-deri ...... ce in pancreatic cancer cells.

@ast

Nuclear factor (erythroid-deri ...... ce in pancreatic cancer cells.

@en

Nuclear factor

@nl

prefLabel

Nuclear factor (erythroid-deri ...... ce in pancreatic cancer cells.

@ast

Nuclear factor (erythroid-deri ...... ce in pancreatic cancer cells.

@en

Nuclear factor

@nl

P1433

Q33527780-CBC5A7C9-44C1-4D86-85CC-3351EFC5177E

P1476

Q33527780-46ACCD29-1564-4BC0-980D-FDCDC7CDBF0C

P2093

Q33527780-0D075BFC-35AD-45CC-98B1-13F77117BBC7

Q33527780-7AB5FF20-4225-46F8-9734-ECF6B7C969EB

Q33527780-7E906543-9B9F-45E1-B690-571D792F4009

Q33527780-903A6BCE-2934-496C-AD02-DFE92CF61C97

Q33527780-93F303E8-33EB-4023-B92D-F3A253E198C4

Q33527780-96850856-CF6F-4363-B784-0FDFAAEE21E1

Q33527780-BBC3B1FD-AF7F-4569-A58F-7DD131C7D0AA

Q33527780-E76FC743-6AE7-438C-88EF-9E4BE73D642A

Q33527780-FFD45FB1-405A-42C9-A944-7F45D7DA5C34

P2860

Q33527780-03CAEB93-9BC8-4918-B06B-99624E03BCA7

Q33527780-054E58B1-D545-4F05-A452-B9BB320594E7

Q33527780-06CADEE9-73AC-4C76-836B-C0623239ED89

Q33527780-147A7797-9FA3-47DB-B5FE-22D626CB1E75

Q33527780-1CE83E3F-38CA-4757-86CF-E4D4020124BA

Q33527780-227441A0-0519-4C90-9D16-4A2C90B2C291

Q33527780-333E0AEE-34A0-4256-B657-9BF72B552604

Q33527780-4DFBA10E-BE87-4761-B6C4-8497A197C016

Q33527780-5244B215-570E-4CFD-B1E4-DFC18BEDED41

Q33527780-59595BB5-B930-4C0D-B5AD-2927598711AB

P304

Q33527780-C663750C-CF33-46BC-880D-AB6F8D795BF0

P31

Q33527780-71C1A4A3-6574-45AF-A8C0-34C05DB17F9A

P356

Q33527780-F259AF46-AA12-43D7-843D-5815E0BEAFF0

P433

Q33527780-4956E2FD-EE59-4DB2-AC22-668A01BFC09C

P478

Q33527780-62611168-BA63-4C35-917C-93E07A3B4B99

P577

Q33527780-11942E0C-A607-4DC5-A9A2-EEBE07BA62B7

P698

Q33527780-2FB4D029-6280-455C-8029-8AC3A167B6DE

P932

Q33527780-55A0DCB3-E4E1-480D-851D-01A9B4653EBC

P356

MPA.0B013E3181C31314

P1433

P1476

Nuclear factor (erythroid-deri ...... ce in pancreatic cancer cells.

@en

P2093

Bhaskar V S Kallakury

http://www.w3.org/2001/XMLSchema#string

Chi Heum Cho

http://www.w3.org/2001/XMLSchema#string

Hee Jeong Kim

http://www.w3.org/2001/XMLSchema#string

Hyo Jin Kang

http://www.w3.org/2001/XMLSchema#string

Insoo Bae

http://www.w3.org/2001/XMLSchema#string

Jong-Min Lee

http://www.w3.org/2001/XMLSchema#string

Kun Young Kwon

http://www.w3.org/2001/XMLSchema#string

Sun Young Kwon

http://www.w3.org/2001/XMLSchema#string

Young Bin Hong

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast

The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress

Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response e

The human ATP-binding cassette (ABC) transporter superfamily

Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer

The role of redox status on chemokine expression in acute pancreatitis

Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway

P304

463-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPA.0B013E3181C31314

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20118824

http://www.w3.org/2001/XMLSchema#string

P932

3506252

http://www.w3.org/2001/XMLSchema#string